• T2 is a fast growing premium Australian tea business with great potential, according to Unilever.
    T2 is a fast growing premium Australian tea business with great potential, according to Unilever.
Close×

Lipton and Bushells brand owner Unilever will acquire Australian tea retailer, T2.

T2 sells a range teas and tea wares from around the world through its 40 stores as well as through cafes and restaurants.

Though Unilever did not disclose the terms of the deal, the company said T2 generated sales of almost $57 million in the 12 months to June 30.

“T2 is a fast growing premium tea business with great potential,” said Kevin Havelock, Unilever president for refreshment.

“This will allow us to bring the benefits of scale and access to new markets to the T2 business and for both businesses to share tea category expertise,” he said.

T2 founder and managing director Maryanne Shearer applauded Unilever's depth of knowledge of tea and its sustainability credentials.

“Both I and the T2 team are looking forward to working alongside new colleagues in Unilever’s tea business to realise the full potential of the business we have spent the last 17 years building,” she said.

Unilever Australasia chairman Clive Stiff said tea was a strategically important category for Unilever Australia.

“We know tea drinkers are increasingly looking for new and diverse tea flavours, so we are delighted to be bringing T2’s premium and exciting range into the fold. T2 is a great Australian success story – a story that we now intend to continue with Unilever,” he said.

Packaging News

Pact Group will delist from the ASX on Wednesday 16 July, the move being the culmination of executive chair and owner Raphael Geminder’s near two-year bid to take full control of the company.

Packaging is at the heart of Suntory’s bold new chapter in Australia, marked by the opening of its $400 million beverage production facility in Swanbank, Queensland – a site purpose-built to deliver high-speed, high-efficiency bottling, canning and kegging through world-class packaging technology and sustainable design.

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.